261 related articles for article (PubMed ID: 25662368)
21. Intermittent parathyroid hormone therapy to increase bone formation.
Thomas T
Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
[TBL] [Abstract][Full Text] [Related]
22. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
23. New anabolic agents in the treatment of osteoporosis.
Hough S
S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
[No Abstract] [Full Text] [Related]
24. [Pharmacology of bone anabolic agents].
Matsumoto T
Nihon Rinsho; 2015 Oct; 73(10):1639-44. PubMed ID: 26529924
[TBL] [Abstract][Full Text] [Related]
25. Emerging anabolic treatments in osteoporosis.
Mosekilde L; Tørring O; Rejnmark L
Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
[TBL] [Abstract][Full Text] [Related]
26. [Control of bone remodeling by bone anabolic drugs.].
Takeuchi Y
Clin Calcium; 2017; 27(12):1767-1774. PubMed ID: 29179172
[TBL] [Abstract][Full Text] [Related]
27. Summary--curing osteoporosis.
Cummings S
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):409. PubMed ID: 15758284
[No Abstract] [Full Text] [Related]
28. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
29. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
30. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
31. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
Goltzman D
Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
[TBL] [Abstract][Full Text] [Related]
32. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
33. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
[TBL] [Abstract][Full Text] [Related]
34. The role of parathyroid hormone in the management of osteoporosis.
Rosen CJ
Horm Res; 2005; 64 Suppl 2():81-5. PubMed ID: 16286779
[TBL] [Abstract][Full Text] [Related]
35. [Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis].
Takeuchi Y
Clin Calcium; 2011 Jan; 21(1):28-32. PubMed ID: 21187591
[TBL] [Abstract][Full Text] [Related]
36. The anabolic effects of parathyroid hormone.
Rubin MR; Cosman F; Lindsay R; Bilezikian JP
Osteoporos Int; 2002; 13(4):267-77. PubMed ID: 12030541
[No Abstract] [Full Text] [Related]
37. Anabolic agents and bone quality.
Sibai T; Morgan EF; Einhorn TA
Clin Orthop Relat Res; 2011 Aug; 469(8):2215-24. PubMed ID: 21132409
[TBL] [Abstract][Full Text] [Related]
38. New understanding and treatments for osteoporosis.
Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
[TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoporosis: role of bone-forming agents.
Reginster JY; Halkin V; Henrotin Y; Gosset C
Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
[No Abstract] [Full Text] [Related]
40. Treating osteoporosis by targeting parathyroid hormone to bone.
Ponnapakkam T; Katikaneni R; Sakon J; Stratford R; Gensure RC
Drug Discov Today; 2014 Mar; 19(3):204-8. PubMed ID: 23932952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
